Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (611-620 of 993) with videos related to

Pageof 100
Sort By:
The Journal of Urology|September 24, 2021
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate CancerFrancesco Chierigo, Mike Wenzel, Christoph Würnschimmel, et al.
European Urology Focus|April 15, 2021
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysisMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
European Urology Focus|September 4, 2021
Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation TherapyStéphane Oudard, Boris Hadaschik, Fred Saad, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2024
The Effect of Adrenalectomy on Overall Survival in Metastatic Adrenocortical CarcinomaAnis Assad, Reha-Baris Incesu, Simone Morra, et al.
European Urology Focus|August 2, 2021
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical ProstatectomyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 4, 2013
Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in CanadaMichael Metcalfe, Wassim Kassouf, Ricardo Rendon, et al.
JAMA Oncology|June 3, 2021
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate CancerFelix Y Feng, Shibu Thomas, Fred Saad, et al.
Urologic Oncology|July 30, 2022
Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Urologic Oncology|April 23, 2024
Prognostic significance of lymph node count in surgically treated patients with T<sub>2-4</sub> stage nonmetastatic adrenocortical carcinomaAnis Assad, Francesco Barletta, Reha-Baris Incesu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2021
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial CarcinomaMarina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, et al.
Pageof 100

Showing results (611-620 of 993) with videos related to

Sort By:
Pageof 100
The Journal of Urology|September 24, 2021
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate CancerFrancesco Chierigo, Mike Wenzel, Christoph Würnschimmel, et al.
European Urology Focus|April 15, 2021
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysisMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
European Urology Focus|September 4, 2021
Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation TherapyStéphane Oudard, Boris Hadaschik, Fred Saad, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2024
The Effect of Adrenalectomy on Overall Survival in Metastatic Adrenocortical CarcinomaAnis Assad, Reha-Baris Incesu, Simone Morra, et al.
European Urology Focus|August 2, 2021
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical ProstatectomyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 4, 2013
Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in CanadaMichael Metcalfe, Wassim Kassouf, Ricardo Rendon, et al.
JAMA Oncology|June 3, 2021
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate CancerFelix Y Feng, Shibu Thomas, Fred Saad, et al.
Urologic Oncology|July 30, 2022
Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Urologic Oncology|April 23, 2024
Prognostic significance of lymph node count in surgically treated patients with T<sub>2-4</sub> stage nonmetastatic adrenocortical carcinomaAnis Assad, Francesco Barletta, Reha-Baris Incesu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2021
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial CarcinomaMarina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, et al.
Pageof 100